Fielder P[au] - Search Results

Year	Number of Results
1986	1
1987	4
1989	2
1990	3
1991	5
1992	6
1993	7
1994	4
1995	4
1996	4
1997	6
1998	5
2001	3
2002	2
2004	2
2005	3
2006	1
2008	3
2010	6
2011	6
2012	9
2013	3
2014	4
2015	1
2016	3
2017	1
2020	1
2021	0

1

A strategy for risk mitigation of antibodies with fast clearance.

Hötzel I, Theil FP, Bernstein LJ, Prabhu S, Deng R, Quintana L, Lutman J, Sibia R, Chan P, Bumbaca D, Fielder P, Carter PJ, Kelley RF. Hötzel I, et al. Among authors: fielder p. MAbs. 2012 Nov-Dec;4(6):753-60. doi: 10.4161/mabs.22189. MAbs. 2012. PMID: 23778268 Free PMC article.

2

Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: what have we learned?

Deng R, Iyer S, Theil FP, Mortensen DL, Fielder PJ, Prabhu S. Deng R, et al. Among authors: fielder pj. MAbs. 2011 Jan-Feb;3(1):61-6. doi: 10.4161/mabs.3.1.13799. Epub 2011 Jan 1. MAbs. 2011. PMID: 20962582 Free PMC article.

3

Implants: Bone physiology and metabolism.

Roberts WE, Turley PK, Brezniak N, Fielder PJ. Roberts WE, et al. Among authors: fielder pj. CDA J. 1987 Oct;15(10):54-61. CDA J. 1987. PMID: 3331974 Review. No abstract available.

4

Physiochemical and biochemical factors influencing the pharmacokinetics of antibody therapeutics.

Bumbaca D, Boswell CA, Fielder PJ, Khawli LA. Bumbaca D, et al. Among authors: fielder pj. AAPS J. 2012 Sep;14(3):554-8. doi: 10.1208/s12248-012-9369-y. Epub 2012 May 18. AAPS J. 2012. PMID: 22610647 Free PMC article. Review.

5

Effects of charge on antibody tissue distribution and pharmacokinetics.

Boswell CA, Tesar DB, Mukhyala K, Theil FP, Fielder PJ, Khawli LA. Boswell CA, et al. Among authors: fielder pj. Bioconjug Chem. 2010 Dec 15;21(12):2153-63. doi: 10.1021/bc100261d. Epub 2010 Nov 5. Bioconjug Chem. 2010. PMID: 21053952 Review.

6

Complex formation of anti-VEGF-C with VEGF-C released during blood coagulation resulted in an artifact in its serum pharmacokinetics.

Bumbaca Yadav D, Reyes AE 2nd, Gupta P, Vernes JM, Meng YG, Schweiger MG, Stainton SL, Fuh G, Fielder PJ, Kamath AV, Shen BQ. Bumbaca Yadav D, et al. Among authors: fielder pj. Pharmacol Res Perspect. 2020 Apr;8(2):e00573. doi: 10.1002/prp2.573. Pharmacol Res Perspect. 2020. PMID: 32125783 Free PMC article.

7

Projecting human pharmacokinetics of monoclonal antibodies from nonclinical data: comparative evaluation of prediction approaches in early drug development.

Wang J, Iyer S, Fielder PJ, Davis JD, Deng R. Wang J, et al. Among authors: fielder pj. Biopharm Drug Dispos. 2016 Mar;37(2):51-65. doi: 10.1002/bdd.1952. Epub 2015 May 15. Biopharm Drug Dispos. 2016. PMID: 25869767 Review.

8

Use of quantitative pharmacology in the development of HAE1, a high-affinity anti-IgE monoclonal antibody.

Putnam WS, Li J, Haggstrom J, Ng C, Kadkhodayan-Fischer S, Cheu M, Deniz Y, Lowman H, Fielder P, Visich J, Joshi A, Jumbe NS. Putnam WS, et al. Among authors: fielder p. AAPS J. 2008 Jun;10(2):425-30. doi: 10.1208/s12248-008-9045-4. Epub 2008 Aug 7. AAPS J. 2008. PMID: 18686041 Free PMC article. Review.

9

The efficacy of recombinant TPO in murine And nonhuman primate models for myelosuppression and stem cell transplantation.

Wagemaker G, Neelis KJ, Hartong SCC, Wognum AW, Thomas GR, Fielder PJ, Eaton DL. Wagemaker G, et al. Among authors: fielder pj. Stem Cells. 1998;16 Suppl 2:127-41. doi: 10.1002/stem.5530160716. Stem Cells. 1998. PMID: 11012185 Free article. Review.

10

Insulin-like growth factor binding proteins and their regulation.

Rosenfeld RG, Pham H, Cohen P, Fielder P, Gargosky SE, Muller H, Nonoshita L, Oh Y. Rosenfeld RG, et al. Among authors: fielder p. Acta Paediatr Suppl. 1994 Apr;399:154-8. doi: 10.1111/j.1651-2227.1994.tb13315.x. Acta Paediatr Suppl. 1994. PMID: 7524821 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results